Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2019-10-15

Original market date: See footnote 1

1993-12-31

Product name:

ULTRAVATE

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

01962701

Product Monograph/Veterinary Labelling:

Date: 2021-05-12 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

BAUSCH HEALTH, CANADA INC.
2150 Boul. St-Elzear Ouest
Laval
Quebec
Canada H7L 4A8

Class:

Human

Dosage form(s):

Cream

Route(s) of administration:

Topical

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

84:06.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

D07AC21 ULOBETASOL

Active ingredient group (AIG) number:See footnote5

0123416001

List of active ingredient(s)
Active ingredient(s) Strength
HALOBETASOL PROPIONATE 0.05 % / W/W
Version 4.0.2
Date modified: